The three business components of Jubilant Pharmova Ltd, which include medicines, contract research and development services, and patented new therapies, make up this integrated global pharmaceuticals corporation.
Financial Results:
- Jubilant Pharmova Ltd. reported Total Income for Q4FY23 of ₹ 1,683 Crores up from ₹ 1,525 Crore year on year, a rise of 10%.
- Total Expenses for Q4FY23 of ₹ 1,786 Crores up from ₹ 1,420 Crores year on year, rise of 26%.
- Consolidated Net Profit of ₹ (101) Crores, down from ₹ 591 Crores in the same quarter of the previous year.
- The Earnings per Share is ₹ (6.15), down from ₹ 3.74 in the same quarter of the previous year.
Most Popular
Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript
Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah
All you need to know about Antony Waste Handling Cell in one article
Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?
Demystifying the Leading Non-Ferrous Recycling Company of India
“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,